Last Updated:
Name Designation Appointment Date Status
Naser Nazeer Patel

Appointed as Designated Partner since August 2025

 Designated Partner 18-Aug-2025 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Glomerulus Pharma Llp.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Mahesh Shinde

Appointed as Designated Partner since August 2025

 Designated Partner 18-Aug-2025 Current
Bapu Ramrao Chege

Appointed as Designated Partner since August 2025

 Designated Partner 18-Aug-2025 Current
Ramesh Kishanrao Jadhav

Appointed as Designated Partner since August 2025

 Designated Partner 18-Aug-2025 Current

People Timeline

Explore the timeline of key personnel in Glomerulus Pharma Llp's leadership journey.

Contact Details
  • Address Svry No. 216 A, Opp. Lahane Hospital, Latur Maharashtra, 413512, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 413512
  • Country India
  • Website -
Frequently Asked Questions
You can contact Glomerulus Pharma Llp through their registered address at Svry No. 216 A, Opp. Lahane Hospital, Latur Maharashtra, 413512, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Glomerulus Pharma Llp are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Naser Nazeer Patel
  • Mahesh Shinde
  • Bapu Ramrao Chege
  • Ramesh Kishanrao Jadhav
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available